Kuik v. Regenxbio, Inc
Kuik v. Regenxbio, Inc is a federal securities / commodities lawsuit filed on 02/13/2026 in the District Court, D. Maryland. The case is currently open in the federal court system.
- Court
- District Court, D. Maryland (D. Maryland)
Official Court Website → - Assigned judge
- Deborah K. Chasanow · 3,731 cases in index
- Docket number
- 8:26-cv-00611
- Cause
- 28:1331 Fed. Question: Securities Violation
28 U.S.C. § 1331 — Federal question jurisdiction - Nature of suit
- 850 Securities/Commodities
Alleged violations of federal securities or commodities laws. - Jurisdiction
- Federal Question
- Jury demand
- Plaintiff
- Date filed
- 02/13/2026
1,144 Securities / Commodities cases in this court are indexed here.
Parties
- plaintiff · Kuik · 3 cases
- defendant · Regenxbio, Inc Pharmaceuticals & Biotechnology · 4 cases
Part of a Larger Litigation Pattern
This is one of 5 Securities / Commodities cases in our index naming REGENXBIO, Inc — a possible mass-tort or coordinated-litigation cluster.
About Securities / Commodities Lawsuits
Securities cases involve alleged violations of federal securities or commodities laws — including fraud, misstatements to investors, insider trading, and shareholder class actions brought under the Securities Act and Securities Exchange Act.
Frequently Asked Questions
What is Kuik v. Regenxbio, Inc?
Kuik v. Regenxbio, Inc is a federal securities / commodities lawsuit filed on 02/13/2026 in the District Court, D. Maryland. The case is currently open in the federal court system. Securities cases involve alleged violations of federal securities or commodities laws — including fraud, misstatements to investors, insider trading, and shareholder class actions brought under the Securities Act and Securities Exchange Act.
What type of case is this?
It is classified as “Securities / Commodities” under the federal nature-of-suit system. Securities cases involve alleged violations of federal securities or commodities laws — including fraud, misstatements to investors, insider trading, and shareholder class actions brought under the Securities Act and Securities Exchange Act.
What court is the case in?
The case is in the District Court, D. Maryland, docket number 8:26-cv-00611.
When was the case filed?
Kuik v. Regenxbio, Inc was filed on 02/13/2026. The case is currently open.
What law is the case brought under?
The docket lists the cause as 28 U.S.C. § 1331 — Federal question jurisdiction.
Other Cases Involving These Parties
Related Securities / Commodities Cases
Source: public U.S. federal court record (docket 72279468).